Ambrosia Biosciences Announces Preclinical Data Supporting Differentiated Profile of AMB-702, its Novel Small Molecule GLP-1 Receptor Agonist Development Candidate

Ambrosia Biosciences Inc. ("Ambrosia"), today announced preclinical data supporting its small molecule GLP-1 receptor agonist ...

Vivid Sydney's final week: flame-cooked desserts, a 4-Oscar filmmaker and the internet's R-rated origin story

Vivid Sydney wraps its 16th year on Saturday 13 June, and the festival has saved a suspicious amount of its best material for ...
Medindia

Novo Nordisk's investigational zenagamtide shows significant A1C reductions with up to 14.6% weight loss in adults with type 2 diabetes--presented at ADA 2026

PLAINSBORO, N.J. and BAGSVÆRD, Denmark, June 5, 2026 /PRNewswire/ -- Novo Nordisk today announced new clinical data from the positive phase 2 trial of investigational zenagamtide, also known as ...
Witfire

FDA’s Digital Liver Break: How AI Toxicology Could Change Drug Development Before Phase I

FDA accepted the first in silico drug development tool under ISTAND to help predict drug-induced liver injury. A data-rich ...